4.6 Article

Nanomedicines targeting the inflammasome as a promising therapeutic approach for cell senescence

Journal

SEMINARS IN CANCER BIOLOGY
Volume 86, Issue -, Pages 46-53

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2022.08.008

Keywords

Nanomedicine; Inflammasome; Neurodegeneration; Ageing; Drug discovery

Categories

Funding

  1. Analytical Chemistry Trust Fund, UK
  2. Royal Society of Chemistry, UK

Ask authors/readers for more resources

This article discusses the application of nanomedicines in aging related disorders and the modulation of signaling molecules in the inflammasome cascade by nanomedicines.
Technological advancements in the present era have enhanced drug discovery and development. Nanomedicines are valuable pharmacotherapeutic tools against several diseases and disorders including aging related disorders. The mechanistic association between nanomedicines and molecular modulation have been investigated by many researchers. Notwithstanding the availability of tremendous amount of data, role of nanomedicines in aging related disorders intending inflammasome transfiguration have not been thoroughly reviewed till now. In the present review, we discuss the application of nanomedicines in aging related disorders. Further, we highlight the recent updates on modulated upstream and downstream signalling molecules of inflammasome cascade due to nanomedicines. The review will benefit researchers targeting nanomedicines as a therapeutic approach towards treatment age related disorders through inflammasome inflection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available